Vaccines are one of the greatest, most affordable weapons in contemporary medicine, yet their reach is underappreciated. We now have vaccines that prevent over 30 potentially fatal diseases and ...

The research is published in the journal Science Advances. Kruyer's lab focuses on relapse to heroin use, as many overdose deaths occur when people overestimate their capacity for drug use during ...

Watch The Outlast Trials trailer for a peek at what's coming in Season 3: Project Relapse of the action horror game. The new chapter of The Outlast Trials extinguishes all hope of future escape ...

Selma Blair shared a positive health update on her battle with multiple sclerosis. The 52-year-old actress, who first announced she had been diagnosed with MS in 2018, revealed Thursday she is ...

"It's funny, I haven't spent enough time having dreams," she said. "And now it's like, what are my dreams?" Lauren Huff is a writer at Entertainment Weekly with over a decade of experience ...

Selma Blair shared that she is “truly relapse-free” from multiple sclerosis (MS) symptoms after a seven-year battle. “I am doing amazingly well. I’ve been feeling great for about a year ...

In January, Variety exclusively reported that Blair was making a return to acting with three new movies entering production: “Stay Forte,” a drama about the Israel-Hamas war; a supernatural ...

While attending The Daily Front Row's 9th Annual Fashion Los Angeles Awards on Thursday, April 24, the 55-year-old actress tells PEOPLE that she is "truly relapse-free" from symptoms of multiple ...

New research from Japan has found that a certain subpopulation of these white blood cells can predict disease relapse at an early stage, which may enable improved personalized treatment.

Researchers trained and validated a deep learning model that can detect subtle changes across post-treatment brain scans and forecast glioma recurrence with up to 89 percent accuracy. Artificial ...

New research from Japan has found that a certain subpopulation of these white blood cells can predict disease relapse at an early stage, which may enable improved personalized treatment.

During a live event, Jack Khouri, MD, discussed options for patients with multiple myeloma after relapse and choices to consider before CAR T-cell therapy. Jack Khouri, MD: In the NCCN guidelines, ...